Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice

scientific article

Hypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/BJC.1996.225
P932PMC publication ID2074519
P698PubMed publication ID8630273
P5875ResearchGate publication ID14570834

P2093author name stringKondo A
Ikeguchi M
Kaibara N
Maeta M
Tsujitani S
Oka A
P2860cites workProtein measurement with the Folin phenol reagentQ20900776
Experimental and clinical status of intraperitoneal chemotherapyQ37858356
Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapyQ38737863
The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexesQ39681341
Intraperitoneal chemotherapy in the management of ovarian cancerQ40875110
Cellular pharmacokinetics of carboplatin and cisplatin in relation to their cytotoxic actionQ41675353
Effect of osmotic pressure on uptake of chemotherapeutic agents by carcinoma cellsQ41727519
The effect of reduced osmolarity on platinum drug toxicityQ41998949
Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repairQ45263039
Intraperitoneal cisplatin: comparison of antitumor activity and toxicity as a function of solvent saline concentration.Q46022350
Ultrafiltration in serum protein binding determinations.Q52741549
Accumulation of cis-diamminedichloroplatinum(II) and platinum analogues by platinum-resistant murine leukemia cells in vitro.Q52832663
Anticancer activity of cis-dichlorodiammineplatinum(II) and some relevant chemistryQ66957055
Analysis of platinum in biological materials by flameless atomic absorption spectrophotometryQ67684183
Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapyQ69609509
Modification of DNA damage in transcriptionally active vs. bulk chromatinQ69619890
Alterations in the toxicity of cis-dichlorodiammineplatinum-II and in tissue localization of platinum as a function of NaCl concentration in the vehicle of administrationQ70668742
Cisplatin metabolites in plasma, a study of their pharmacokinetics and importance in the nephrotoxic and antitumour activity of cisplatinQ70798079
Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicleQ70953842
Plasma platinum levels: relationship to cisplatin dose and nephrotoxicityQ71228108
Effects of low salt concentration on structural organization and template activity of chromatin in chicken erythrocyte nucleiQ71771368
Intraperitoneal cisplatin during surgery for gastric cancer and peritoneal seedingQ72672886
Graphical estimation of relative potency from quantal responsesQ76054129
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectchemotherapyQ974135
peritoneal carcinomatosisQ2071182
cisplatinQ412415
P304page(s)1166-1170
P577publication date1996-05-01
P1433published inBritish Journal of CancerQ326309
P1476titleHypotonic intraperitoneal cisplatin chemotherapy for peritoneal carcinomatosis in mice
P478volume73